FRANKFURT (Dow Jones) – At Fresenius Medical Care (FMC) there is another change at the top after a few weeks. As the dialysis provider announced late Monday evening, the board of directors has appointed Chief Financial Officer and Deputy CFO Helen Giza as CEO effective December 6. Carla Kriwet, who only took up her post on October 1, is leaving the company at her own request and by mutual agreement due to strategic differences. Giza will remain Chief Financial Officer of Fresenius Medical Care AG & Co. KGaA until further notice.
“In a fundamentally healthy industry, Fresenius Medical Care must focus even more on the operational turnaround, further improve company performance and concentrate on its core,” said the CEO of the parent company Fresenius SE, Michael Sen, according to the announcement. Giza is “eminently suited to lead the company on the path ahead.”
Contact the author: [email protected]
DJG/mgo/kla
(END) Dow Jones Newswires
December 06, 2022 00:16 ET (05:16 GMT)
Leverage must be between 2 and 20
No data